Unravelling the Complexity of Cancer
Recent advances in genomics have taught us that cancer is not one condition, but a spectrum of distinct diseases, each caused by a specific combination of genetic and epigenetic changes. With this knowledge, we’ve also learned that there is no “one-size-fits-all” solution to eradicate cancer. Traditional, non-specific treatments often do not achieve lasting therapeutic responses for the vast majority of cancer patients, while even the newest therapies (such as immunotherapy) work well for some patients but not for others. Better outcomes for cancer patients will only be achieved through targeted and personalized approaches, attainable only through research. The Rosalind and Morris Goodman Cancer Research Centre (GCRC) is leading the way, uniting fundamental and clinical cancer researchers working across scientific disciplines to illuminate the distinct biology underlying aggressive cancer types.
Collaborate to Cure
These are exciting times for cancer research. GCRC-based collaborative networks are addressing unmet clinical needs with a patient-centric approach – beginning with clinical samples and observations that come from cancer patients. We are developing innovative technologies that are already leading to new and better ways to diagnose, treat and ultimately cure cancers. With a deeper understanding of the unique factors driving specific cancers, we are designing new personalized strategies to attack their weaknesses and vulnerabilities. Our world-leading experts and talented trainees in the fields of cancer biology, clinical oncology, computer science, mathematics, engineering and physics are bringing these solutions from the laboratory to the bedside.